Literature DB >> 20825901

Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study.

Philippe Frontin1, Vincent Bounes, Charles Henri Houzé-Cerfon, Sandrine Charpentier, Vanessa Houzé-Cerfon, Jean Louis Ducassé.   

Abstract

STUDY
OBJECTIVE: The purpose of this randomized controlled trial was to determine the immediate and delayed effects of noninvasive ventilation for patients in acute cardiogenic pulmonary edema (ACPE) in addition to aggressive usual care in a medical prehospital setting.
METHODS: Out-of-hospital patients in severe ACPE were eligible for the study. Patients were randomized to receive either usual care, including conventional optimal treatment with furosemide, oxygen, and high-dose boluses of isosorbide dinitrate plus oxygen, or conventional medications plus out-of-hospital continuous positive airway pressure (CPAP). The primary outcome was the treatment success defined as all of respiratory rate less than 25 breaths per minute and oxygen saturation of greater than 90% at the end of 1-hour study. Secondary end points included death during 30 days after inclusion. Lengths of intensive care unit and hospital stays were also recorded.
RESULTS: In total, 124 patients were enrolled into the study. The 2 groups had similar baseline characteristics. For the primary outcome analysis, 22 (35.5%) of 62 patients were considered as experiencing a treatment success in the usual care group vs 19 (31.7%) of 60 in the CPAP group (P = .65). Seven patients died within 30 days in the usual care group vs 6 in the CPAP group (P = .52). There were no statistically significant differences between the treatment groups for length of stay either in hospital or in the intensive care unit.
CONCLUSION: In the prehospital setting, in spite of its potential advantages for patients in ACPE, CPAP may not be preferred to a strict optimal intravenous treatment.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825901     DOI: 10.1016/j.ajem.2010.03.007

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours.

Authors:  Christian Michael Horvath; Martin Hugo Brutsche; Otto Dagobert Schoch; Bernarde Schillig; Florent Baty; Dieter vonOw; Jochen Julius Rüdiger
Journal:  Intern Emerg Med       Date:  2016-10-08       Impact factor: 3.397

Review 2.  Continuous positive airway pressure and noninvasive ventilation in prehospital treatment of patients with acute respiratory failure: a systematic review of controlled studies.

Authors:  Skule A Bakke; Morten T Botker; Ingunn S Riddervold; Hans Kirkegaard; Erika F Christensen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-11-22       Impact factor: 2.953

3.  Prehospital treatment with continuous positive airway pressure in patients with acute respiratory failure: a regional observational study.

Authors:  Vibe Maria Laden Nielsen; Jacob Madsen; Anette Aasen; Anne Pernille Toft-Petersen; Kenneth Lübcke; Bodil Steen Rasmussen; Erika Frischknecht Christensen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-10-10       Impact factor: 2.953

4.  Adult Patients with Respiratory Distress: Current Evidence-based Recommendations for Prehospital Care.

Authors:  Sammy S Hodroge; Melody Glenn; Amelia Breyre; Bennett Lee; Nick R Aldridge; Karl A Sporer; Kristi L Koenig; Marianne Gausche-Hill; Angelo A Salvucci; Eric M Rudnick; John F Brown; Gregory H Gilbert
Journal:  West J Emerg Med       Date:  2020-06-25

Review 5.  Non-invasive Positive Pressure Ventilation for Acute Cardiogenic Pulmonary Edema and Chronic Obstructive Pulmonary Disease in Prehospital and Emergency Settings.

Authors:  Ansha P Abubacker; Andrew Ndakotsu; Harsh V Chawla; Aimen Iqbal; Amit Grewal; Revathi Myneni; Govinathan Vivekanandan; Safeera Khan
Journal:  Cureus       Date:  2021-06-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.